
Opinion|Videos|May 3, 2024
Impact Of Durable Agents on Treatment Burden and Quality of Life in Retinal Diseases
The panel concludes its discussion with thoughts on the profound impact durable treatments have on the quality of life of patients with retinal diseases.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
4
The Residency Report: Cardiovascular risk scores as a window into ocular disease
5


















